U.S. Physical Therapy, Inc. USPH
Set alert
85.83 USD -0.74 -0.85%
At close · Oct 30
85.83 0.00 0.00%
After hours · Oct 30, 4:01 PM ET
85.19 Day range 87.62
59.00 52-week range 88.73
- YTD
- +9.91%
- 1 year
- -0.45%
- Open
- 87.26
- Prev close
- 86.57
- Mkt cap
- 1.28B
- Vol
- 146.43K
- Avg vol
- 184.54K
- EPS
- 0.18
- P/E
- 476.83
- Div yield
- 2.13%
More statistics
- Low
- 85.19
- High
- 87.62
- Forward P/E
- 25.69
- Beta
- 1.11
- Short ratio
- 6.28
- Inst. own
- 112.49%
- Dividend
- 1.84
- Ex-div date
- Aug 20, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 82.66
- 200-d avg
- 76.75
- 1y target
- 97.83
2Y chart
Events in this range
- Nov 15, 2024Dividend: 0.44
- Mar 14, 2025Dividend: 0.45
- May 23, 2025Dividend: 0.45
- Aug 6, 2025Earnings: 0.81; estimate 0.71; surprise 14.08%
- Aug 22, 2025Dividend: 0.45
- Nov 5, 2025Earnings: 0.66; estimate 0.67; surprise -1.49%
- Nov 17, 2025Dividend: 0.45
- Feb 20, 2026Rating: Barrington Research · Outperform → Outperform
- Feb 25, 2026Earnings: 0.67; estimate 0.67; surprise 0%
- Mar 13, 2026Dividend: 0.46
- May 6, 2026Earnings: 0.46; estimate 0.55; surprise -16.36%
- May 8, 2026Rating: Citizens · Market Outperform → Market Outperform
- May 13, 2026Rating: Barrington Research · Outperform → Outperform
- May 22, 2026Dividend: 0.46
- Jun 24, 2026Rating: Citizens · Market Outperform → Market Outperform
- Aug 5, 2026Earnings: 0.75; estimate 0.814; surprise -7.86%
- Aug 10, 2026Rating: Barrington Research · Outperform → Outperform
- Aug 21, 2026Dividend: 0.46
- Sep 11, 2026Rating: JP Morgan · Overweight → Overweight
Signals (78)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 28, 2026 | 3 days ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 5, 2026 | 3 weeks ago |
| RSI: Overbought | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| RSI: Overbought | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| RSI: Oversold | May 7, 2026 | 5 months ago |
| RSI: Oversold | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| RSI: Oversold | Mar 19, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Feb 27, 2026 | 8 months ago |
| SMA: Bearish | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 31, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 11 months ago |
| RSI: Oversold | Nov 6, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 28, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 24, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 21, 2025 | 1 year ago |
| RSI: Overbought | Oct 7, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 26, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 27, 2025 | 1 year ago |
| RSI: Overbought | Aug 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| MACD: Sell Signal | May 27, 2025 | 1 year ago |
| RSI: Overbought | May 15, 2025 | 1 year ago |
| SMA: Bullish | May 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| RSI: Oversold | Mar 18, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 18, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
Key statistics
- Market cap
- 1.28B
- Enterprise value
- 1.97B
- Trailing P/E
- 474.94
- Forward P/E
- 25.69
- PEG ratio
- 2.84
- Price / sales
- 1.59
- Price / book
- 2.84
- EPS (TTM)
- 0.18
- Beta
- 1.11
- Dividend yield
- 2.13%
- Payout ratio
- 1011.11%
- Profit margin
- 4.01%
- Revenue (TTM)
- 804.27M
- Revenue growth
- 8.50%
- Free cash flow
- 41.29M
- Total cash
- 26.26M
- Total debt
- 385.79M
- Return on equity
- 6.51%
- Shares outstanding
- 14.92M
- Short % of float
- 9.58%
- 50-day average
- 82.66
- 200-day average
- 76.75
Analyst view
Consensus: buy
Buy
Price target (mean) 97.83 +14.0% upside
Now 85.83
- Target (low)
- 95.00
- Target (mean)
- 97.83
- Target (high)
- 101.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy4
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.725.
Financials — quick view
USPH Revenue — quarterly 214.06M
USPH Net income — quarterly 9.90M
USPH EPS — quarterly 0.25
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.756 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.814 | 0.75 | -0.06 | -7.86% |
| May 6, 2026 | Mar 31, 2026 | 0.55 | 0.46 | -0.09 | -16.36% |
| Feb 25, 2026 | Dec 31, 2025 | 0.67 | 0.67 | 0.00 | 0.00% |
| Nov 5, 2025 | Sep 30, 2025 | 0.67 | 0.66 | -0.01 | -1.49% |
| Aug 6, 2025 | Jun 30, 2025 | 0.71 | 0.81 | +0.10 | +14.08% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 11, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 10, 2026 | Barrington Research | main | Outperform | Outperform |
| Jun 24, 2026 | Citizens | reit | Market Outperform | Market Outperform |
| May 13, 2026 | Barrington Research | main | Outperform | Outperform |
| May 8, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Feb 20, 2026 | Barrington Research | main | Outperform | Outperform |
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- usph.com
News
- Aristotle Small/Mid Cap Equity WM Q3 2026 Portfolio Activity
- U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates
- U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
- Transcript: US Physical Therapy Q2 2026 Earnings Conference Call
- JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95
- Freestone Grove Partners LP Makes New Investment in U.S. Physical Therapy, Inc. $USPH
- BlackRock Inc. Invests $155.50 Million in U.S. Physical Therapy, Inc. $USPH
- U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
- U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
- U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
Your note
Sign in to keep a note on USPH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BINSTEIN RICHARD S | General Counsel | Sale | Mar 5, 2026 | 24,867 |
| GILMARTIN KATHLEEN A | Director | Stock Award(Grant) | May 18, 2026 | 27,092 |
| HARRIS BERNARD A. JR | Director | Stock Award(Grant) | May 18, 2026 | 20,914 |
| HENDRICKSON CAREY P | Chief Financial Officer | Stock Award(Grant) | Feb 22, 2026 | 37,808 |
| MOTSENBOCKER ANNE | Director | Stock Award(Grant) | May 18, 2026 | 9,812 |
| READING CHRISTOPHER J | Chief Executive Officer | Stock Award(Grant) | Feb 22, 2026 | 139,088 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.17% | 2,264,202 | 193.57M | Jun 29, 2026 |
| Copeland Capital Management, LLC | 6.30% | 940,528 | 80.41M | Sep 29, 2026 |
| Bahl & Gaynor LLC | 5.77% | 861,574 | 73.66M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 5.67% | 846,674 | 72.38M | Jun 29, 2026 |
| State Street Corporation | 4.74% | 707,186 | 60.46M | Jun 29, 2026 |
| Morgan Stanley | 4.68% | 698,690 | 59.73M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 888,029 | 75.92M | Sep 29, 2026 |
| ETF Series Solutions-Bahl & Gaynor Small/Mid Cap Income Growth ETF | 3.89% | 581,135 | 49.68M | Jun 29, 2026 |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 3.78% | 563,592 | 48.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.25% | 484,591 | 41.43M | Jun 29, 2026 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 2.84% | 424,530 | 36.29M | Jul 30, 2026 |
| Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund | 2.64% | 393,615 | 33.65M | Jun 29, 2026 |